ArticleHaematologica2022

The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era.

Camille C B Kockerols et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.